130 related articles for article (PubMed ID: 9708402)
21. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.
De Paoli P; Zanussi S; Caggiari L; Bortolin MT; D'Andrea M; Simonelli C; Tirelli U
J Clin Immunol; 1999 Sep; 19(5):317-25. PubMed ID: 10535609
[TBL] [Abstract][Full Text] [Related]
23. Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.
Lee S; Almeida CA; French MA; Price P
Clin Exp Immunol; 2004 Oct; 138(1):110-5. PubMed ID: 15373912
[TBL] [Abstract][Full Text] [Related]
24. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
[TBL] [Abstract][Full Text] [Related]
25. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.
Herbeuval JP; Nilsson J; Boasso A; Hardy AW; Vaccari M; Cecchinato V; Valeri V; Franchini G; Andersson J; Shearer GM
AIDS; 2009 Jan; 23(1):35-40. PubMed ID: 19050384
[TBL] [Abstract][Full Text] [Related]
26. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
27. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the tonsil cytokine milieu favors HIV susceptibility.
Moutsopoulos NM; Vázquez N; Greenwell-Wild T; Ecevit I; Horn J; Orenstein J; Wahl SM
J Leukoc Biol; 2006 Nov; 80(5):1145-55. PubMed ID: 16943383
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
[TBL] [Abstract][Full Text] [Related]
30. Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients.
Caggiari L; Zanussi S; Bortolin MT; D'andrea M; Nasti G; Simonelli C; Tirelli U; De Paoli P
Clin Exp Immunol; 2000 Apr; 120(1):101-6. PubMed ID: 10759770
[TBL] [Abstract][Full Text] [Related]
31. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
Brazille P; Dereuddre-Bosquet N; Leport C; Clayette P; Boyer O; Vildé JL; Dormont D; Benveniste O
Clin Exp Immunol; 2003 Feb; 131(2):304-11. PubMed ID: 12562393
[TBL] [Abstract][Full Text] [Related]
32. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
33. Chemokine receptors expression on T cells and response to HAART among chronic HIV-1-infected subjects.
Brito A; Rigato PO; Almeida A; Fernandes SS; Gonsalez CR; Fonseca LA; Duarte AJ; Casseb J
Curr HIV Res; 2008 Nov; 6(6):539-43. PubMed ID: 18991619
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
Garrido M; Mozos A; Martínez A; García F; Serafín A; Morente V; Caballero M; Gil C; Fumero E; Miró JM; Climent N; Gatell JM; Alos L
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):268-74. PubMed ID: 17786132
[TBL] [Abstract][Full Text] [Related]
36. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy.
Voltersvik P; Bostad L; Dyrhol-Riise AM; Eide GE; Røsok BI; Olofsson J; Asjö B
J Acquir Immune Defic Syndr; 2006 Mar; 41(3):277-84. PubMed ID: 16540928
[TBL] [Abstract][Full Text] [Related]
37. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
[TBL] [Abstract][Full Text] [Related]
38. Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2.
De Paoli P; Bortolin MT; Zanussi S; Monzoni A; Pratesi C; Giacca M
Clin Exp Immunol; 2001 Sep; 125(3):440-6. PubMed ID: 11531952
[TBL] [Abstract][Full Text] [Related]
39. Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients.
Clerici M; Seminari E; Maggiolo F; Pan A; Migliorino M; Trabattoni D; Castelli F; Suter F; Fusi ML; Minoli L; Carosi G; Maserati R;
AIDS; 2002 Sep; 16(13):1767-73. PubMed ID: 12218388
[TBL] [Abstract][Full Text] [Related]
40. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).
Stellbrink HJ; van Lunzen J; Westby M; O'Sullivan E; Schneider C; Adam A; Weitner L; Kuhlmann B; Hoffmann C; Fenske S; Aries PS; Degen O; Eggers C; Petersen H; Haag F; Horst HA; Dalhoff K; Möcklinghoff C; Cammack N; Tenner-Racz K; Racz P
AIDS; 2002 Jul; 16(11):1479-87. PubMed ID: 12131185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
